[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"ParaNano, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100619812","a-pac-post-market-clinical-study-to-demonstrate-color-change-in-the-woundcue-kit-when-an-elevated-inhibitory-bacterial-andor-fungal-load-is-present-in-a-wound-100619812",false,"NCT07349485","A PAC Post-Market Clinical Study to Demonstrate Color Change in the WoundCue™ Kit When an Elevated Inhibitory Bacterial and\u002For Fungal Load is Present in a Wound","Inclusion Criteria:\n\n* Arm 1:\n\nSubjects will be considered qualified for enrollment if they meet the following criteria:\n\nSubjects and\u002For Legally Authorized Representative (LAR) must voluntarily provide written Informed Consent, consisting of reading, signing, and dating the Informed Consent document after the Principal Investigator, sub-Principal Investigator, or other designated Study Staff member has explained the Study procedures, risks, and contact information.\n\nAble and willing to comply with all Study requirements.\n\nSubject can be Male or Female but must be over 21 years of age.\n\nSubject is currently under the care of a Primary Care Physician.\n\nSubject has an anticipated survival of greater than two months.\n\nSubject has a moderate to high exudate wound that has visible fluorescence when using MolecuLightDX™ or MolecuLight i:X™ imaging.\n\nArm 2:\n\nSubjects will be considered qualified for enrollment if they meet the following criteria:\n\nSubjects and\u002For Legally Authorized Representative (LAR) must voluntarily provide written Informed Consent, consisting of reading, signing, and dating the Informed Consent document after the Principal Investigator, sub-Investigator, or other designated Study Staff member has explained the Study procedures, risks, and contact information.\n\nAble and willing to comply with all Study requirements.\n\nSubject can be Male or Female but must be over 21 years of age.\n\nSubject is currently under the care of a Primary Care Physician.\n\nSubject has an anticipated survival of greater than two months.\n\nSubject has a moderate to high exudate wound.\n\n\\*For this Study, moderate exudate is defined as a wound that may require a dressing change 2-3 times a week based on provider judgement. Heavy exudate is defined as a wound that may require a dressing change 4 or more times a week based on provider judgement.\n\nExclusion Criteria:\n\n* Subject's target treatment area has a surface area larger than 5 cm2.\n\nKnown sensitivity or allergy to the Study Device or adhesives\u002Fadhesive-related products.\n\nCurrent use of topical ointments, including over-the-counter products and prescription drugs, on or near the intended treatment area.\n\nCurrent use or recent history (within the past 14 days) of antibiotics, either oral, systemic, or topical.\n\nUndergoing therapy with another investigational agent that may affect the WoundCueTM Kit's performance within thirty (30) days of Study Visit 1 or planned participation overlapping with this Study.\n\nWomen who are pregnant, breastfeeding, or intend to become pregnant during the course of the Study.\n\nMedical condition that, in the opinion of the Principal Investigator, would preclude safe Subject participation in the Study.\n\nAdults who, in the judgment of the Investigator, lack the capacity to provide informed consent for themselves","ALL","21 Years",{"count":18,"type":19},50,"ESTIMATED","INTERVENTIONAL",[22],"NA","The purpose of this research is to test if the investigational ParaNano WoundCue Kit can detect elevated inhibitory bacterial and\u002For fungal loads.",[25],"Wound Care","NOT_YET_RECRUITING","2026-01-27",{"date":29,"type":30},"2026-01-29","ACTUAL",{"date":32,"type":19},"2026-01-21",{"date":34,"type":19},"2027-11-20",{"name":36,"class":37},"ParaNano, Inc.","INDUSTRY",""]